INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 127 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 2.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,728,873 | -32.0% | 501,033 | -37.4% | 0.12% | -36.9% |
| Q4 2022 | $9,896,000 | -11.3% | 800,000 | 0.0% | 0.20% | -11.4% |
| Q3 2022 | $11,160,000 | +1.0% | 800,000 | 0.0% | 0.22% | -6.8% |
| Q2 2022 | $11,048,000 | -15.1% | 800,000 | 0.0% | 0.24% | +15.7% |
| Q1 2022 | $13,016,000 | +144.0% | 800,000 | +144.3% | 0.20% | +200.0% |
| Q4 2021 | $5,334,000 | -57.0% | 327,444 | +227.4% | 0.07% | -80.5% |
| Q4 2019 | $12,392,000 | -46.0% | 100,000 | -51.2% | 0.35% | -55.8% |
| Q1 2019 | $22,931,000 | +35.4% | 205,000 | +22.0% | 0.79% | +5.2% |
| Q4 2018 | $16,933,000 | – | 168,000 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Carmignac Gestion | 1,993,592 | $284,446,000 | 2.44% |
| ELEMENT CAPITAL MANAGEMENT LLC | 95,512 | $13,628,000 | 2.06% |
| RTW INVESTMENTS, LP | 39,500 | $5,636,000 | 1.93% |
| Orbimed Advisors | 1,120,000 | $159,802,000 | 1.67% |
| FT Options LLC | 12,900 | $1,814,000 | 1.56% |
| Marcus Capital, LLC | 10,250 | $1,462,000 | 1.54% |
| Ghost Tree Capital, LLC | 35,000 | $4,994,000 | 1.44% |
| BB BIOTECH AG | 255,719 | $36,486,000 | 1.44% |
| FT Options LLC | 10,779 | $1,538,000 | 1.32% |
| ALTRINSIC GLOBAL ADVISORS LLC | 284,230 | $40,554,000 | 1.14% |